Close
fr
nl
en
A
A
Terms of use
Privacy policy
Site Map
Pfizer
Working for a healthier world
Recherchez dans le site :
Patiënten
Pfizer Pro
Dierenartsen
Sollicitanten
Media
Investeerders
Leveranciers
pfizer Movie
Over Pfizer België / Luxemburg
Wie zijn we?
Wat doen we?
Pfizer in België/Luxemburg
Partner in gezondheidszorg
Publicaties & Standpunten
Veelgestelde vragen
Op zoek naar een Pfizer-geneesmiddel?
Selectie op therapeutisch domein
Cardiovasculair
Centraal zenuwstelsel
Endocrinologie
Gastro-enterologie
Gynaecologie
Gynecologie
Infectiologie
Oftalmologie
Oncologie
Reumatologie
Urologie
Selectie op productnaam
ACCUPRIL
ACCURETIC
ADRIBLASTINA
ALDACTAZINE
ALDACTONE
AMLOR
AMSIDINE
ARICEPT
AROMASIN
ARTHROTEC
CAMPTO
CARBOPLATINUM
CAVERJECT
CELEBREX
CELSENTRI
CHAMPIX
CIPRALAN
CLOZAN
COLESTID
CYTOSAR
CYTOTEC
DALACIN C
DALACIN TOPICAL
DALACIN VAGINAL
DEPO-MEDROL
DEPO-MEDROL + LIDOCAINE
DEPO-PROVERA 150
DEPO-PROVERA 500
DEPO-PROVERA SC
DEPRONAL
DETRUSITOL
DETRUSITOL RETARD
DIFLUCAN
DIFLUCAN IV
DOSTINEX
DYNASTAT
ECALTA
EDRONAX
EPANUTIN
ESTRACYT
ESTRADURINE
FARLUTAL
FARMORUBICINE
FASIGYN
FELDENE
FLUROBLASTINE
FRAGMIN
GABBRORAL
GENOTONORM
GLIBENESE
HALCION
INSPRA
KETALAR
LINCOCIN
LIPITOR
LYRICA
LYSANXIA
MACUGEN
MEDROL
MINIDIAB
MINIPRESS
MYCOBUTIN
NARDELZINE
NAXOGIN
NEURONTIN
OLBETAM
PREPIDIL
PROSTIN 15M
PROSTIN VR
PROSTINE E2
PROVERA
RELERT
REVATIO
SALAZOPYRINE
SELECTOL
SELOZIDE
SERLAIN
SINEQUAN
SOLDACTONE
SOLU-CORTEF
SOLU-MEDROL
SOMAVERT
SOSTILAR
SUTENT
TERRA-CORTRIL (HUIDZALF / ONGUENT DERMIQUE)
TERRA-CORTRIL OOR- en OOGSUSPENSIE
TERRAMYCINE HUIDZALF
TERRAMYCINE OOGZALF - POMMADE OPHTALMIQUE
TOVIAZ
TRAZOLAN
TROBICIN
VALTRAN
VFEND
VIAGRA
VIBRATAB
VISTIDE
XALACOM
XALATAN
XANAX
ZARONTIN
ZAVEDOS
ZITROMAX
ZOK-ZID
ZYVOXID
Actualiteiten
Pfizer vraagt een recht op anwoord voor een artikel verschenen in het n° 95 van Test Gezondheid
10/02/2010
HAITI-LAVI 12-12
05/02/2010
Pfizer start een studiebeurs op in "Health Technology Assessment"
29/01/2010
Persberichten
PFIZER ANIMAL HEALTH WELCOMES AGREEMENT WITH ELANCO ON DIVESTED EUROPEAN ASSETS
08/03/2010
Lilly, Merck, And Pfizer Join Forces To Accelerate Research And Improve Treatment Of Lung And Gastric Cancers In Asia
23/02/2010
QIAGEN Unit And Pfizer Enter Into An Agreement To Develop A Companion Diagnostic For Brain Tumor Patients
05/02/2010
“Wyeth is now a part of Pfizer. The merger of local Wyeth and Pfizer entities may be pending in various jurisdictions and is subject to completion of various local legal and regulatory obligations. Accordingly, changes will not become effective outside of the U.S. and Puerto Rico until the relevant in-country Go-Live date. Until that time, Pfizer and Wyeth must continue to operate as two separate companies. All content in this message is subject to works council and/or union consultations and other legal requirements.”